TITANIUM (IV) OXIDE ANATASE -325 Manufacturer , exporter, supplier by MEDIOCON INC
TITANIUM (IV) OXIDE ANATASE -325
Manufactured by MEDIOCON INC
Name: TITANIUM(IV) OXIDE ANATASE, -325
CAS No: 1317-70-0
Molecular Weight: 79.866 g/mol
Molecular formula :TiO2
Synonyms: Titanium dioxide, titanium(IV) oxide, titania,
Pigment White 6 (PW6), CI 77891, E171 (when used as a food coloring).
Appearance: white
fine powder.
Solubility :
Insoluble in water, dilute
acids, and organic solvents. Slowly soluble in hot concentrated sulfuric acid
and hydrofluoric acid.
Use :
Primarily used
as a white pigment and opacifier in paints, coatings, plastics, papers, inks,
and cosmetics (sunscreens). Also used in acid-resistant vitreous enamels,
welding rod coatings, and as a photocatalyst in various applications
How is TITANIUM(IV) OXIDE ANATASE,
-325 manufactured by MEDIOCON INC Synthesized?
- Sulfate Process: This older, batch process involves digesting
ilmenite ore or titanium slag in concentrated sulfuric acid. A series of
steps including chemical reduction, purification, hydrolysis to form
titanium hydrate, and final calcination (heating) at 900–1000°C yields the
final anatase titanium dioxide pigment.
- Chloride Process: This continuous process requires a higher-purity
ore (rutile or synthetic rutile) which is chlorinated at high temperatures
(850–1000°C) to produce titanium tetrachloride
TiCl4TiCl sub 4
TiCl4
is then purified and
burned with air or oxygen at even higher temperatures (1200–1370°C) to produce
TiO2TiO sub 2
TiO2
. This method
typically yields the rutile form, but specific conditioning can produce
anatase.
Laboratory/Specialty Synthesis Methods
For smaller-scale production or specific
high-purity applications, such as for the "trace metals basis" product
offered by Mediocon (similar to the product code T 7609 mentioned in a source),
various wet-chemical methods are used to control particle size and crystal
structure (anatase):
- Sol-Gel Method: This is a common method for synthesizing
nano-sized anatase particles at lower temperatures. It typically involves
the hydrolysis of a titanium alkoxide precursor (e.g., titanium tetra
isopropoxide) in the presence of water and a solvent, often with an acid
or organic modifier to control the reaction and prevent agglomeration.
- Hydrothermal
Synthesis: Titanium oxide
can be prepared using hydrolysis of titanyl sulfate or titanium
tetrachloride under high temperature and pressure in an aqueous solution.
What are the different dosage
forms of TITANIUM(IV) OXIDE ANATASE, -325
Manufactured by MEDIOCON INC?
Mediocon Inc. manufactures TITANIUM(IV) OXIDE ANATASE, "-325" exclusively in a powder form. It is not produced as a finished pharmaceutical "dosage form" by this manufacturer, but rather as a raw material or an ingredient for use in other applications, including potential pharmaceutical manufacturing.
Key points regarding
the product:
·
Form: It is supplied as an anatase powder with a particle size
of -325 mesh (meaning the particles can pass through a 325 mesh sieve). The
average diameter is approximately 45 µm.
·
Use: As a raw material, it is used by other companies who then
incorporate it into various final products, such as pharmaceutical tablets,
capsules, creams, and coatings.
· Manufacturer Role: Mediocon Inc. acts as a manufacturer and supplier of pharmaceutical raw materials, API intermediates, and industrial chemicals.
You can find more details on the company's offerings on their official
website or their IndiaMART profile.
.
How TITANIUM(IV) OXIDE ANATASE,
-325 Manufactured by MEDIOCON INC Dosage Forms are prepared?
TITANIUM(IV) OXIDE ANATASE, -325" manufactured
by MEDIOCON INC is likely sold as a raw material in powder form for use in
pharmaceutical manufacturing processes, not as a pre-prepared "dosage
form" itself. Titanium dioxide is widely used in solid oral dosage forms
(like tablets and capsules) as a colorant, opacifier, and to ensure
batch-to-batch homogeneity of appearance.
The raw titanium dioxide material is processed by
pharmaceutical manufacturers using methods such as film coating or suspension
preparation to incorporate it into final dosage forms:
·
Tablet Coating: Titanium
dioxide is a key ingredient in the coating solutions applied to tablets. The
manufacturing process involves preparing a suspension or solution of the
titanium dioxide powder along with other excipients (binders, film-forming
polymers, etc.), which is then sprayed onto the tablet cores in specialized
coating equipment. The -325 mesh size indicates a very fine powder, which aids
in creating a uniform suspension and smooth coating.
·
Capsule Preparation: It is also used in the manufacturing of opaque capsule shells.
·
Suspensions: The
finely divided particles can be kept in suspensions used for various
pharmaceutical applications.
In summary, the MEDIOCON INC product is an intermediate or raw material supplied as a fine
powder, and its "dosage form" is ultimately determined by the
specific formulation and manufacturing process employed by the pharmaceutical
company that purchases it.
What are the appropriate Dosage forms of
TITANIUM(IV) OXIDE ANATASE, -325
Manufactured by MEDIOCON INC?
The Titanium(IV) oxide anatase powder supplied by
MEDIOCON INC is an excipient used primarily as a colorant and opacifier in
various oral solid and semi-solid
dosage forms.
The appropriate dosage forms for which this
material is used as an ingredient include:
·
Tablets (used
in film-coatings and as a colorant)
·
Hard capsules
·
Soft capsules
·
Granules/powders for oral solution and oral
suspensions
·
Oral paste/gel (primarily
in veterinary medicinal products)
This specific product from MEDIOCON INC, described
as "-325" mesh, is a powder. It is typically incorporated into a
formulation during the manufacturing process of these dosage forms.
When should TITANIUM(IV) OXIDE ANATASE,
-325 Manufactured by MEDIOCON INC be taken?
A method of
improving the stability, mitigating degradation, including oxidation, or both
of photo or thermosensitive ingredients of cosmetics, personal care and
pharmaceutical / medicinal compositions or of cosmetics, personal care, and
pharmaceutical / medicinal compositions containing photo or thermosensitive
ingredients , wherein said photo or thermal sensitive ingredients are selected
from photo or thermo sensitive sunscreen actives, colorants, dyes, organic
pigments, tocopherols, organic peroxides, polyunsaturated color compounds,
antioxidants, flavor ingredients, fragrances, vitamins, thickening agents
polymeric that have no unsaturation, and oils and waxes, said method comprises
the addition of an effective amount of a compound according to the following
formula I: ** Formula ** where R1 and R2, which may be the same or different,
are independently H or a linear or branched alkyl or alkoxy of 1 to 8 carbon
atoms and R3 is a linear lower alkyl The branched 2 to 8 carbon atoms of the
photo or thermosensitive ingredient or cosmetic, personal care, pharmaceutical
/ medicinal compositions containing the same or both.
What are the effects And Side effects
of TITANIUM(IV) OXIDE ANATASE, -325 Manufactured by MEDIOCON INC?
The effects and side effects of Titanium(IV) Oxide Anatase, -325 from
MEDIOCON INC are related to general titanium dioxide properties, with health
concerns primarily linked to inhalation and,
potentially, ingestion, due
to its fine particle size ("-325" refers to a very fine mesh size).
Dermal exposure typically poses minimal risk on healthy skin.
Effects and Uses
Titanium(IV) oxide (TiO₂) in its anatase form is a white powder widely used
as a pigment, opacifier, and in various industrial and scientific applications
due to its high reactivity and surface area.
·
Pigment and Opacifier: Provides whiteness and opacity in paints, cosmetics, plastics,
papers, inks, pharmaceuticals (tablet coatings, capsules), and some foods.
·
UV Resistance/Absorption: Used in sunscreens and materials to absorb UV
light.
·
Scientific/Industrial: Utilized in photocatalysis and as a standard light-scattering
suspension in laboratory settings.
Side Effects and Health Risks
The primary health concerns stem from exposure to
fine or nano-sized particles, as the physical characteristics (size, shape,
crystal phase) influence toxicity. The anatase form may be more cytotoxic to
certain cells than the rutile form.
·
Inhalation (Primary Risk):
o
Respiratory Problems: Inhaling the dust can irritate the eyes, nose, and throat.
Long-term exposure can lead to chronic bronchitis, shortness of breath,
wheezing, and coughing.
o
Cancer Risk: The
International Agency for Research on Cancer (IARC) classifies airborne, unbound
particles of respirable-size titanium dioxide as a Group 2B carcinogen
(possibly carcinogenic to humans) based on animal studies that showed lung
tumors.
o
Lung Damage: Can
cause lung inflammation and potentially fibrosis.
·
Ingestion:
o
While
historically used as a food additive (E171), the European Food Safety Authority
(EFSA) concluded in 2021 that it can no longer be considered safe for
consumption due to potential genotoxicity (ability to damage DNA).
o
Animal
studies indicate that ingested nanoparticles can accumulate in organs,
potentially causing intestinal inflammation, liver and kidney dysfunction, and
damage to neurons.
How is TITANIUM(IV) OXIDE
ANATASE, -325 Manufactured by MEDIOCON INC Tested
Qualitatively?
The specific qualitative testing procedures
used by MEDIOCON INC are proprietary and not publicly available, but standard
industry practices for titanium(IV) oxide powder involve a variety of tests to
confirm its identity, phase, and purity
.
Standard Qualitative Testing for Titanium
Dioxide (Anatase)
Qualitative testing of titanium(IV) oxide,
anatase grade, typically focuses on verifying its chemical composition, crystal
structure, and physical properties.
- X-Ray Diffraction
(XRD): This is the definitive qualitative
method for confirming the presence of the anatase crystal structure and ensuring the absence (or
minimal presence) of the rutile or brookite phases. The unique diffraction
pattern acts as a fingerprint for the material's crystalline form.
- Fourier Transform
Infrared Spectroscopy (FTIR): FTIR is used to
identify the characteristic O-Ti-O bonding in the anatase morphology and
to detect the presence of any residual organic species (which might be
present if the material was manufactured using a sol-gel method and
calcination was incomplete).
- Chemical
Identification Test (Peroxo Complex Formation): A chemical test can be performed by
digesting the sample in concentrated sulfuric acid and then adding
hydrogen peroxide (
H2O2cap H sub 2 cap O
sub 2
𝐻2𝑂2
). The formation of a
characteristic yellow-to-orange colored peroxo complex indicates the presence
of titanium ions.
- Whiteness and Color
Assessment: As titanium
dioxide is a primary white pigment, its whiteness is a crucial quality indicator.
This is often assessed visually or using a whiteness meter to ensure it
meets the required standards, which is a key physical characteristic for
its use in paints, coatings, and pharmaceuticals.
- Solubility Test: Titanium dioxide is notably insoluble in
water and most dilute acids. A simple test would involve attempting to
dissolve a sample in water to confirm this characteristic.
- Particle Size
Verification: The "-325
mesh" specification refers to the particle size (meaning the powder
passes through a 325 mesh sieve, roughly <45 µm average diameter).
While often a quantitative measurement, a simple sieve analysis
qualitatively confirms the general fineness of the powder.
Which tests are performed on TITANIUM(IV)
OXIDE ANATASE, -325 Manufactured by MEDIOCON INC ?
For MEDIOCON INC's Titanium(IV) Oxide Anatase (-325 mesh), standard quality tests likely focus on its physical form (powder, particle size -325 mesh), chemical purity (assay $\ge$99%), crystal structure (anatase), and trace metal content, with specific functional tests (like dispersibility, UV absorption, photocatalysis) depending on its intended use (e.g., pharma, cosmetics, industrial pigment), often involving X-ray Diffraction (XRD) for crystal form, SEM for morphology, and assays for heavy metals.
Key Tests Performed (General for this Type of TiO2)
Tests generally ensure the material meets specifications for purity, particle
characteristics, and performance, as suggested by similar products.
1.
Identity
& Purity:
·
Assay: Verifying high purity, often $\ge$99% (e.g., trace metals
basis).
·
X-Ray Diffraction (XRD): Confirming the anatase crystal structure and checking for
rutile/brookite impurities.
2.
Physical
Properties:
·
Particle Size Analysis: Confirming the "-325 mesh" (fine powder)
specification, indicating controlled particle size.
·
Scanning Electron Microscopy (SEM): Visualizing particle morphology and agglomeration.
·
Specific
Surface Area: Measured via BET
analysis, crucial for photocatalytic/dispersing properties.
3.
Trace
Element Analysis:
·
Inductively
Coupled Plasma (ICP) Spectroscopy: Detecting
and quantifying trace metals (e.g., Pb, As, Hg, Cd) for safety, especially for
food/pharma grades.
4.
Functional
Performance (Application-Dependent):
·
Photocatalytic
Activity: Testing degradation of pollutants
(like ibuprofen) if used for environmental applications.
·
Optical
Properties: Assessing light
scattering/whiteness for pigment use.
·
Toxicity Tests (if
for Pharma/Food): Ames test for
genotoxicity, cytotoxicity assays (though often debated in 2D vs. 3D models).
What
are the challenges in Manufacturing of Banana Extract Manufactured by
MEDIOCON INC API?
Manufacturing banana extract as an API by MEDIOCON INC API likely faces general API challenges like strict regulatory compliance (FDA, WHO-GMP), maintaining process consistency and quality control, ensuring sustainable sourcing of raw biomass, efficient downstream processing (extraction & purification) to get high yields and purity, and overcoming supply chain disruptions for raw materials like banana biomass, plus the added complexity of scaling up natural product extraction.
Here are the
key challenge areas:
1. Sourcing & Supply Chain:
·
Raw
Material Consistency: Ensuring a steady,
high-quality supply of banana biomass (peels, pseudostems, etc.) as feedstock,
which can vary with seasons, weather, and geography, poses a major hurdle.
· Sustainability: Managing the large volumes of biomass waste generated from banana cultivation and processing sustainably is crucial to avoid environmental issues.
2. Extraction &
Purification (Downstream Processing):
·
Yield
& Purity: Developing cost-effective,
high-yield methods to extract specific bioactive compounds while separating
them from impurities is a significant technical challenge.
· Scale-Up: Scaling laboratory extraction methods (like microwave-assisted extraction or using green solvents) to industrial levels without introducing new impurities or losing efficiency requires careful process optimization.
3. Quality &
Regulatory Compliance:
·
Batch-to-Batch
Variability: Natural products
are prone to variability; ensuring consistent API quality (potency, impurity
profile) across batches is a core challenge.
· Global Standards: Meeting stringent regulations from bodies like the FDA (US) and WHO-GMP (World Health Organization Good Manufacturing Practices) requires robust quality systems and continuous updates.
4. Process
Technology & Economics:
·
Process
Intensification: Implementing
efficient, potentially continuous, extraction and separation technologies
(e.g., continuous crystallization, membrane separation) can reduce
costs but requires significant investment and expertise.
· Cost-Effectiveness: Balancing advanced technology and sustainable practices with competitive pricing in the global API market is a constant challenge.
5. Environmental
Impact:
·
Waste
Management: Handling byproduct
streams from the extraction process and treating pharmaceutical wastewater
sustainably are critical concerns for modern API manufacturers.
What are the challenges in manufacturing
of TITANIUM(IV) OXIDE ANATASE, -325 Manufactured by MEDIOCON INC ’s
Dosage forms?
The primary manufacturing challenges for dosage
forms containing titanium(IV) oxide anatase from suppliers like MEDIOCON INC
relate to regulatory compliance, achieving consistent and optimal product
quality attributes (like whiteness and opacity), and addressing the technical
complexity of reformulation when alternatives are required.
Key Challenges in Manufacturing
·
Regulatory Hurdles: The European Food Safety Authority (EFSA) concluded in 2021 that
food-grade titanium dioxide (E171) can no longer be considered safe for food
use, leading to a ban in the EU. This creates a significant challenge for
globally operating pharmaceutical companies, which must navigate disparate
international regulations and potentially reformulate products for specific
markets.
·
Maintaining Product Quality and Performance: Titanium dioxide (TiO₂) provides unique properties, including high
refractive index, exceptional whiteness, opacity, and protection of the active
pharmaceutical ingredient (API) from UV light, which are difficult to replicate
with alternative materials. Replacing it often results in:
o
Color Fading and Variability: Alternative coatings may lack the color stability
of TiO₂, leading to inconsistent product appearance.
o
Processing Issues: Substitutes may not work well in high-speed manufacturing equipment or
be compatible with standard coating systems, affecting manufacturing
efficiency.
o
Loss of Functionality: Finding alternatives that provide the same level of opacity and light
protection is challenging, potentially impacting the stability and shelf-life
of the drug product.
·
Particle Size and Form Consistency: The specific "anatase, -325"
designation refers to a particular crystal form and particle size (passing
through a 325 mesh screen). Maintaining a consistent particle size distribution
and crystal phase (anatase is metastable and can transform to rutile at high
temperatures) is crucial for reproducible performance and quality control.
·
Scale-Up Risk: While
alternatives might show promise in lab settings, scaling up production often
introduces unforeseen technical complexities, cost issues, and stability
problems.
·
Potential for Impurities and Toxicity Concerns: Although typically considered safe when not
inhaled or ingested in large quantities, the use of fine-particle or nano-sized
TiO₂ in dosage forms raises concerns about potential
accumulation in organs. Manufacturers must ensure high purity, specifically
removing trace transition metals and heavy elements, to meet stringent
pharmaceutical specifications.
What is the Packing for TITANIUM(IV)
OXIDE ANATASE, -325 Manufactured by MEDIOCON INC?
TITANIUM(IV) OXIDE ANATASE, -325 is
typically packed in various sizes, including:
- 25Kg Bag: Commonly used for industrial
and pharmaceutical applications
- 20 Kg Bag: Also available for specific
requirements
- 100g, 500g, and 2Kg: Smaller packs for
laboratory and research purposes
- Drum: Used for larger quantities, often
in pharmaceutical manufacturing
The packaging may vary depending on the
supplier and intended use
What is shelf life Of TITANIUM(IV) OXIDE
ANATASE, -325 Manufactured by MEDIOCON INC?
The novel gel-coat
with added titanium dioxide and alumina particles described in this patent is
directly applicable in the field of construction for the external part of
construction material surfaces or urban elements, in the transport sector,
given that this type of material possesses photocatalytic properties that allow
it to break down NOx currently found in large cities. Moreover, said novel
material possesses self-cleaning, biocidal and deodorising properties that
allow applications in the maritime transport sector, where it may help to
overcome the resistance induced by the attachment of marine life to the hulls
of boats, and may reduce the costs of cleaning same.
What should the label claim for TITANIUM(IV)
OXIDE ANATASE, -325 Manufactured by MEDIOCON INC Include?
For Titanium(IV) Oxide Anatase -325 by MEDIECON INC, label claims should include its chemical identity (Titanium Dioxide, TiO2), crystal form (Anatase), particle size (<-325 mesh), purity (e.g., 99%), manufacturer, and appropriate hazard/safety info (like inhalation warnings if applicable, though EU regs are changing) for its intended use, as it's a white pigment for coatings, plastics, inks, or cosmetics, often regulated by bodies like FDA, ECHA, or Health Canada depending on application.
Key Information to Include on the Label:
1.
Product
Name: Titanium(IV) Oxide, Anatase.
2.
Chemical
Formula: TiO2 (Titanium Dioxide).
3.
Particle
Size: "-325 mesh" (indicating
very fine powder).
4.
Manufacturer: MEDICON INC.
5.
Purity/Grade: Specify purity (e.g., 99%) or grade (e.g., Qualified
Grade).
6.
Crystal
Form: Anatase (important for optical
properties).
7.
Physical
Form: Soft, white dry powder.
8.
CAS
Number: 13463-67-7 (for regulatory
identification).
9. Intended Use: (e.g., Pigment for Paints & Coatings, Cosmetic Ingredient, Food Additive if applicable).
Where
can TITANIUM(IV) OXIDE ANATASE, -325 Manufactured by MEDIOCON INC are procured?
TITANIUM(IV) OXIDE ANATASE, -325 Manufactured
by MEDIOCON INC can be procured from various sources,
depending on your location and requirements. Here are some options:
FOR API
MEDIOCON
INC
Add: B-2, ARCH SARTHAK BUILDING, N-7 CIDCO
CHATRAPATI SAMBHAJI NAGAR-431003,
MAHARASHTRA, INDIA
Mob/Whatsapp No:
+91-8007719681, +91-9309999757, +91-9834786939
Sales Department: Email: sales@mediocon.com
Purchase Department: Email: purchase@mediocon.com
Marketing Department: Email: mktg@mediocon.com
HR Department: Email: hr@mediocon.com
Accounts Department: Email: accounts@mediocon.com
Factory Address: Plot No 11, Shendra MIDC,
Aurangabad-431154, Maharashtra, India Website: www.mediocon.com
Email id:info@mediocon.com
GST No: 27DHUPM2366D1ZZ
For
Dosage Forms :
- Online Marketplaces: You can find TITANIUM(IV)
OXIDE ANATASE, -325 Manufactured by MEDIOCON INC products
on online marketplaces like Amazon or e- commerce websites
specializing in pharmaceuticals or skincare products.
Local Pharmacies or Skincare Stores: You
can also check with local pharmacies or skincare stores in your area for TITANIUM(IV)
OXIDE ANATASE, -325 Manufactured by MEDIOCON INC products.
Remember to ensure the quality and
authenticity of the TITANIUM(IV) OXIDE ANATASE, -325 Manufactured by
MEDIOCON INC product, regardless of the procurement source.
Comments
Post a Comment